Organ-on-a-chip platform

Lena Biosciences is seeking partners to validate, manufacture and commercialise their micro-organ perfusion platform, PerfusionPal, to reduce animal use in drug testing. The platform enables delivery, distribution and testing of slow-clearing biologicals, small molecule drugs and antibody-drug conjugates in a standard multiwell format suitable for most assays and readout equipment. Academic and industrial collaborators are sought for further development, validation and manufacture of PerfusionPal. For further information please see the flyer.

PDF - 257.9 KB